Profiling the Bladder Microbiota in Patients With Bladder Cancer.

actinobacteria bladder cancer microbiota sequencing

Journal

Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977

Informations de publication

Date de publication:
2021
Historique:
received: 01 06 2021
accepted: 22 12 2021
entrez: 24 2 2022
pubmed: 25 2 2022
medline: 25 2 2022
Statut: epublish

Résumé

Evidence suggests that microbiota may contribute to the pathogenesis of several diseases, including cancer. In the case of bladder cancer, preliminary studies have found alterations in the urinary microbiota of patients with urothelial carcinoma compared with healthy individuals. Conversely, the urinary microbiota differ between men and women, and it has been hypothesized that these differences are associated with the lower incidence of bladder cancers in women. The objective of this study was to characterize the bladder microbiota in paired samples of tumor and non-tumor mucosa of patients with malignant bladder neoplasia using next-generation sequencing. In addition, we aimed to study potential differences in microbial composition in tumor samples according to clinical and pathological variables, and to determine possible microbial profiles. We found significant differences in microbial richness at the genus level, with a higher richness observed in the non-tumor compared with the tumor mucosa. It was also shown that

Identifiants

pubmed: 35197936
doi: 10.3389/fmicb.2021.718776
pmc: PMC8859159
doi:

Types de publication

Journal Article

Langues

eng

Pagination

718776

Informations de copyright

Copyright © 2022 Parra-Grande, Oré-Arce, Martínez-Priego, D’Auria, Rosselló-Mora, Lillo, Sempere, Lumbreras and Sánchez-Hellín.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

JAMA Oncol. 2015 Dec;1(9):1282-90
pubmed: 26448641
J Transl Med. 2012 Aug 28;10:174
pubmed: 22929533
Science. 2015 Apr 3;348(6230):80-6
pubmed: 25838377
Am J Clin Exp Urol. 2014 Apr 15;2(1):57-61
pubmed: 25126590
Gut Pathog. 2013 Mar 07;5(1):2
pubmed: 23497613
Cell Host Microbe. 2013 Aug 14;14(2):207-15
pubmed: 23954159
Nat Commun. 2018 Apr 19;9(1):1557
pubmed: 29674608
Eur Urol. 2019 Apr;75(4):637-646
pubmed: 30655087
J Urol. 2006 Dec;176(6 Pt 1):2474-81; discussion 2481
pubmed: 17085133
J Med Microbiol. 2019 Oct;68(10):1471-1478
pubmed: 31418671
Ann Transl Med. 2015 Sep;3(16):229
pubmed: 26539446
Best Pract Res Clin Gastroenterol. 2017 Dec;31(6):643-648
pubmed: 29566907
Oncogenesis. 2014 Jun 09;3:e105
pubmed: 24911876
Front Cell Infect Microbiol. 2013 Aug 15;3:41
pubmed: 23967406
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Nature. 2010 Mar 4;464(7285):59-65
pubmed: 20203603
Mol Microbiol. 2001 Nov;42(3):729-40
pubmed: 11722738
Front Nutr. 2018 May 24;5:44
pubmed: 29881727
Sci Rep. 2018 Aug 14;8(1):12157
pubmed: 30108246
Front Cell Infect Microbiol. 2018 May 31;8:167
pubmed: 29904624
Bioinformatics. 2011 Nov 1;27(21):2957-63
pubmed: 21903629
World J Urol. 2011 Aug;29(4):457-63
pubmed: 21656173
Clin Infect Dis. 2011 Nov;53(9):870-8
pubmed: 21960713
Front Microbiol. 2015 Feb 02;6:20
pubmed: 25699023
mBio. 2014 Jul 08;5(4):e01283-14
pubmed: 25006228
Front Microbiol. 2019 Jun 12;10:1317
pubmed: 31244818
Eur Urol. 2013 Feb;63(2):234-41
pubmed: 22877502
Nat Rev Urol. 2015 Feb;12(2):81-90
pubmed: 25600098
Nucleic Acids Res. 2014 Jan;42(Database issue):D633-42
pubmed: 24288368
Nat Rev Urol. 2016 Feb;13(2):77-90
pubmed: 26666363
Nat Rev Microbiol. 2012 Jun 25;10(8):575-82
pubmed: 22728587
Free Radic Biol Med. 2002 Sep 15;33(6):818-26
pubmed: 12208369
Eur J Epidemiol. 2017 Mar;32(3):255
pubmed: 28013490
Genome Biol. 2011 Jun 24;12(6):R60
pubmed: 21702898
Genome Res. 2012 Feb;22(2):292-8
pubmed: 22009990
Eur Urol. 2017 Jan;71(1):109-110
pubmed: 27417034
Bioinformatics. 2011 Mar 15;27(6):863-4
pubmed: 21278185
Eur J Obstet Gynecol Reprod Biol. 2017 Jul;214:31-35
pubmed: 28463826
Cancer Med. 2019 Nov;8(16):6904-6914
pubmed: 31568654

Auteurs

Mónica Parra-Grande (M)

Department of Microbiology, Hospital General Universitario de Elche, Elche, Spain.

Martín Oré-Arce (M)

Departament of Oncology, Hospital Marina Baixa de La Vila Joiosa, Villajoyosa, Spain.

Llúcia Martínez-Priego (L)

Sequencing and Bioinformatics Service, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, FISABIO, Valencia, Spain.

Giuseppe D'Auria (G)

Sequencing and Bioinformatics Service, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, FISABIO, Valencia, Spain.

Ramón Rosselló-Mora (R)

Marine Microbiology Group, Institut Mediterrani d'Estudis Avançats (CSIC-UIB), Esporles, Spain.

Marta Lillo (M)

Biobank, Hospital General Universitario de Elche, Elche, Spain.

Andrea Sempere (A)

Biobank, Hospital General Universitario de Elche, Elche, Spain.

Blanca Lumbreras (B)

Departament of Public Health, Hystory of Science and Gynecology, CIBER en Epidemiología y Salud Pública (CIBERESP), Miguel Hernández University, Elche, Spain.

Victoria Sánchez-Hellín (V)

Department of Microbiology, Hospital General Universitario de Elche, Elche, Spain.

Classifications MeSH